Citius Pharmaceuticals, Inc.
-$31.69M- Market cap
- $16.13M
- Debt
- +-$6.11M
- Cash
- −$41.71M
Capital structure 161% equity / -61% debt · EV / EBITDA 0.96x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
CTXR · current priceP/S 179.27x
$0.59Latest market snapshot
Implied fair value · at NWSA's multiple
$0.0198.9% below market
0.00 CTXR revenue / share×1.95x NWSA P/S=$0.01
Market $0.59Implied $0.01
NWSA · current priceP/S 1.95x
$30.39Latest market snapshot
Implied fair value · at CTXR's multiple
$2,908.199,469.6% above market
16.22 NWSA revenue / share×179.27x CTXR P/S=$2,908.19
Market $30.39Implied $2,908.19